Goat Milk Infant Formula Comfort Study

Status Completed

Clinical Trial Summary

In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops.

Clinical Trial Description

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this randomized controlled pilot study, the effect on comfort during usage of goat-milk based infant formula is studied. Twenty formula fed infants (aged between 6 weeks and 3 months) who experience mild discomfort will receive goat milk-based infant formula (GMF) or cow's mik based infant formula supplemented with probiotics lactobacillus reuteri drops (CMFp). The infants will be assessed by a local paediatricians using the Cow's Milk-related Symptom Score (CoMiSS). This is a fast, non-invasive and easy-to-use and validated questionnaire to assess infant's reaction to proteins found in cow's milk. The higher the score, the more sensitive the child is to cow's milk proteins, the maximum score is 33 points. Infants with a CoMiSS Score between 6 and 12 will be enrolled in this study. It is expected that infants will have a better response to GMF, which will result in a decrease of the CoMiSS Score after a 2 weeks intervention. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06301139
Study type	Interventional
Source	Ausnutria Hyproca B.V.
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2019
Completion date	February 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02541357` - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery	N/A
Active, not recruiting	`NCT02358122` - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh	N/A
Active, not recruiting	`NCT02442115` - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation	`NCT00943345` - Validation of New Tests for Gastrointestinal (GI) Permeability	Phase 0
Completed	`NCT00612404` - Symptoms and Endoscopic Results in Consideration of Pretreatment	N/A
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Recruiting	`NCT05712525` - Gut Recovery In Patients Following Surgery
Recruiting	`NCT06094153` - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function	N/A
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed	`NCT02486146` - GI Biorepository of Tissue and Bodily Fluids	N/A
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT00247715` - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Recruiting	`NCT06286865` - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial	N/A
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT03725813` - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit	N/A
Recruiting	`NCT05640401` - Holographic Screens as a Replacement of Monitors During GI Endoscopies	N/A
Completed	`NCT02865564` - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics	N/A
Completed	`NCT02651857` - Exploratory Study of Upper and Lower Endoscopic Fuse System	N/A
Active, not recruiting	`NCT01984034` - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines	N/A